You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨生物醫藥股大跌 特朗普稱美國將對藥品徵收關稅
格隆匯 04-09 10:00
受關稅消息影響,生物醫藥股大跌,其中,再鼎醫藥、百濟神州跌超9%,藥明康德、藥明合聯跌7.6%,君實生物、藥明生物、復宏漢霖跌超6%,金斯瑞生物科技、泰格醫藥、康方生物皆下挫。消息上,美國總統特朗普當地時間4月8日發表講話稱,美國將對藥品徵收關稅。特朗普表示,美國並不生產自己的藥品和其他改善健康的產品。美國支付藥品的價格往往比有藥品生產的國家高出很多倍。特朗普認爲,一旦對藥品徵收關稅,製藥公司將在美國開設工廠,因爲美國是“最大的市場”。(格隆匯)

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account